• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:白长焕,孔令甲,申肖华,焦波.整合素连接激酶(ILK)在肾脏疾病中的研究进展[J].中国现代应用药学,2018,35(8):1265-1268.
BAI Changhuan,KONG Lingjia,SHEN Xiaohua,JIAO Bo.Research Progress of Integrin-linked Kinase(ILK) in Renal Diseases[J].Chin J Mod Appl Pharm(中国现代应用药学),2018,35(8):1265-1268.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3707次   下载 2654 本文二维码信息
码上扫一扫!
分享到: 微信 更多
整合素连接激酶(ILK)在肾脏疾病中的研究进展
白长焕,孔令甲,申肖华,焦波
山东省聊城市第二人民医院,山东省聊城市第二人民医院,山东省聊城市第二人民医院,.山东大学药学院药理室
摘要:
整合素连接激酶(integrin-linked kinase,ILK)是一种丝氨酸/苏氨酸蛋白激酶,可与整合素β1、β3亚基胞浆域结合,参与整合素、生长因子、Wnt及TGF-β/Smad等多种信号转导,在调节细胞黏附、凋亡、转移、生长、细胞周期、肿瘤形成等过程中起重要作用。细胞中ILK表达异常,将引发病理变化。本文综述了ILK的生物学活性及其与肾脏疾病的关系,提示ILK的表达调控可能成为治疗肾脏疾病的新途径。
关键词:  肾脏疾病  整合素连接激酶  信号转导
DOI:10.13748/j.cnki.issn1007-7693.2018.08.033
分类号:R963
基金项目:
Research Progress of Integrin-linked Kinase(ILK) in Renal Diseases
baichanghuan,konglingjia,shenxiaohua and jiaobo
The Second People's Hospital of Liaocheng,The Second People's Hospital of Liaocheng,The Second People's Hospital of Liaocheng,Shandong University
Abstract:
Integrin-linked kinase(ILK) is a serine/threonine protein kinase, which interacts with the cytoplasmic domain of integrin β1 and β3 and participates in signal transduction such as integrin, growth factor, Wnt and TGF-beta/Smad. It plays an important role in the regulation of cell adhesion, apoptosis, metastasis, growth, cell cycle, tumor formation and so on. Abnormal expression of ILK in cells may lead to pathological changes. In this paper, the biological activity of ILK and its relationship with kidney diseases were summarized. These data suggest that the regulation of ILK expression may be a new approach for the treatment of renal diseases.
Key words:  kidney disease  integrin-linked kinase  signal transduction
扫一扫关注本刊微信